BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ehrenberg AJ, Suemoto CK, França Resende EP, Petersen C, Leite REP, Rodriguez RD, Ferretti-Rebustini REL, You M, Oh J, Nitrini R, Pasqualucci CA, Jacob-Filho W, Kramer JH, Gatchel JR, Grinberg LT. Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease. J Alzheimers Dis 2018;66:115-26. [PMID: 30223398 DOI: 10.3233/JAD-180688] [Cited by in Crossref: 55] [Cited by in F6Publishing: 30] [Article Influence: 18.3] [Reference Citation Analysis]
Number Citing Articles
1 Kim NG, Lee HW. Stereoscopic Depth Perception and Visuospatial Dysfunction in Alzheimer's Disease. Healthcare (Basel) 2021;9:157. [PMID: 33546119 DOI: 10.3390/healthcare9020157] [Reference Citation Analysis]
2 Barker MS, Cosentino SA, Fremont R, Devanand DP, Huey ED. Towards Defining the Neuroanatomical Basis of Late-Onset Psychiatric Symptoms. J Geriatr Psychiatry Neurol 2022;:8919887221090213. [PMID: 35380884 DOI: 10.1177/08919887221090213] [Reference Citation Analysis]
3 Nunes PV, Suemoto CK, Rodriguez RD, Paraizo Leite RE, Nascimento C, Pasqualucci CA, Nitrini R, Jacob-filho W, Grinberg LT, Lafer B. Neuropathology of depression in non-demented older adults: a large postmortem study of 741 individuals. Neurobiology of Aging 2022. [DOI: 10.1016/j.neurobiolaging.2022.05.007] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Kelberman MA, Anderson CR, Chlan E, Rorabaugh JM, McCann KE, Weinshenker D. Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease. J Alzheimers Dis 2022. [PMID: 35147547 DOI: 10.3233/JAD-215546] [Reference Citation Analysis]
5 de Aguiar GPCG, Saraiva MD, Khazaal EJB, de Andrade DC, Jacob-Filho W, Suemoto CK. Persistent pain and cognitive decline in older adults: a systematic review and meta-analysis from longitudinal studies. Pain 2020;161:2236-47. [PMID: 32453132 DOI: 10.1097/j.pain.0000000000001932] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Huda TI, Diaz MJ, Gozlan EC, Chobrutskiy A, Chobrutskiy BI, Blanck G. Immunogenomics Parameters for Patient Stratification in Alzheimer's Disease. J Alzheimers Dis 2022. [PMID: 35662120 DOI: 10.3233/JAD-220119] [Reference Citation Analysis]
7 Uiterwijk D, Stargatt R, Crowe SF. Objective Cognitive Outcomes and Subjective Emotional Sequelae in Litigating Adults with a Traumatic Brain Injury: The Impact of Performance and Symptom Validity Measures. Arch Clin Neuropsychol 2022:acac039. [PMID: 35704852 DOI: 10.1093/arclin/acac039] [Reference Citation Analysis]
8 Umstead A, Vega IE. Tau13 Antibody Preferentially Immunoprecipitates High Molecular Weight Tau Proteins. J Alzheimers Dis 2019;68:511-6. [PMID: 30814358 DOI: 10.3233/JAD-181187] [Reference Citation Analysis]
9 Ashford JW. The Dichotomy of Alzheimer's Disease Pathology: Amyloid-β and Tau. J Alzheimers Dis 2019;68:77-83. [PMID: 30814359 DOI: 10.3233/JAD-181198] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
10 Ismail Z, Creese B, Aarsland D, Kales HC, Lyketsos CG, Sweet RA, Ballard C. Psychosis in Alzheimer disease - mechanisms, genetics and therapeutic opportunities. Nat Rev Neurol 2022. [PMID: 34983978 DOI: 10.1038/s41582-021-00597-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
11 David M, Malhotra PA. New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease. Ann Clin Transl Neurol 2022. [PMID: 35293158 DOI: 10.1002/acn3.51539] [Reference Citation Analysis]
12 Gottesman RT, Stern Y. Behavioral and Psychiatric Symptoms of Dementia and Rate of Decline in Alzheimer's Disease. Front Pharmacol 2019;10:1062. [PMID: 31616296 DOI: 10.3389/fphar.2019.01062] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
13 Kelberman M, Keilholz S, Weinshenker D. What's That (Blue) Spot on my MRI? Multimodal Neuroimaging of the Locus Coeruleus in Neurodegenerative Disease. Front Neurosci 2020;14:583421. [PMID: 33122996 DOI: 10.3389/fnins.2020.583421] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
14 Pedemonte M, Brockmann PE, DelRosso LM, Andersen ML. Past, present, and future of sleep medicine research in Latin America. J Clin Sleep Med 2021;17:1133-9. [PMID: 33583492 DOI: 10.5664/jcsm.9152] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ramos AR, Tarraf W, Wu B, Redline S, Cai J, Daviglus ML, Gallo L, Mossavar-Rahmani Y, Perreira KM, Zee P, Zeng D, Gonzalez HM. Sleep and neurocognitive decline in the Hispanic Community Health Study/Study of Latinos. Alzheimers Dement 2020;16:305-15. [PMID: 31606367 DOI: 10.1016/j.jalz.2019.08.191] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
16 Cacabelos R, Carril JC, Corzo L, Fernández-Novoa L, Pego R, Cacabelos N, Cacabelos P, Alcaraz M, Tellado I, Naidoo V. Influence of Pathogenic and Metabolic Genes on the Pharmacogenetics of Mood Disorders in Alzheimer's Disease. Pharmaceuticals (Basel) 2021;14:366. [PMID: 33920985 DOI: 10.3390/ph14040366] [Reference Citation Analysis]
17 Alosco ML, Cherry JD, Huber BR, Tripodis Y, Baucom Z, Kowall NW, Saltiel N, Goldstein LE, Katz DI, Dwyer B, Daneshvar DH, Palmisano JN, Martin B, Cantu RC, Stern RA, Alvarez VE, Mez J, Stein TD, McKee AC. Characterizing tau deposition in chronic traumatic encephalopathy (CTE): utility of the McKee CTE staging scheme. Acta Neuropathol 2020;140:495-512. [PMID: 32778942 DOI: 10.1007/s00401-020-02197-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 11.5] [Reference Citation Analysis]
18 Manca R, Valera-Bermejo JM, Venneri A; Alzheimer’s Disease Neuroimaging Initiative. Accelerated atrophy in dopaminergic targets and medial temporo-parietal regions precedes the onset of delusions in patients with Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 2022. [PMID: 35554669 DOI: 10.1007/s00406-022-01417-5] [Reference Citation Analysis]
19 Lennon JC, Aita SL, Bene VAD, Rhoads T, Resch ZJ, Eloi JM, Walker KA. Black and White individuals differ in dementia prevalence, risk factors, and symptomatic presentation. Alzheimers Dement 2021. [PMID: 34854531 DOI: 10.1002/alz.12509] [Reference Citation Analysis]
20 Santacruz Escudero JM, Beltrán J, Palacios Á, Chimbí CM, Matallana D, Reyes P, Perez-Sola V, Santamaría-García H. Neuropsychiatric Symptoms as Predictors of Clinical Course in Neurodegeneration. A Longitudinal Study. Front Aging Neurosci 2019;11:176. [PMID: 31396074 DOI: 10.3389/fnagi.2019.00176] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
21 Mendez MF. The Relationship Between Anxiety and Alzheimer's Disease. J Alzheimers Dis Rep 2021;5:171-7. [PMID: 33981954 DOI: 10.3233/ADR-210294] [Reference Citation Analysis]
22 Oh JY, Walsh CM, Ranasinghe K, Mladinov M, Pereira FL, Petersen C, Falgàs N, Yack L, Lamore T, Nasar R, Lew C, Li S, Metzler T, Coppola Q, Pandher N, Le M, Heuer HW, Heinsen H, Spina S, Seeley WW, Kramer J, Rabinovici GD, Boxer AL, Miller BL, Vossel K, Neylan TC, Grinberg LT. Subcortical Neuronal Correlates of Sleep in Neurodegenerative Diseases. JAMA Neurol 2022. [PMID: 35377391 DOI: 10.1001/jamaneurol.2022.0429] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet 2020;396:413-46. [PMID: 32738937 DOI: 10.1016/S0140-6736(20)30367-6] [Cited by in Crossref: 580] [Cited by in F6Publishing: 309] [Article Influence: 290.0] [Reference Citation Analysis]
24 Chen Y, Dang M, Zhang Z. Brain mechanisms underlying neuropsychiatric symptoms in Alzheimer's disease: a systematic review of symptom-general and -specific lesion patterns. Mol Neurodegener 2021;16:38. [PMID: 34099005 DOI: 10.1186/s13024-021-00456-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Buciuc M, Tosakulwong N, Machulda MM, Whitwell JL, Weigand SD, Murray ME, Reichard RR, Parisi JE, Dickson DW, Boeve BF, Knopman DS, Petersen RC, Josephs KA. TAR DNA-Binding Protein 43 Is Associated with Rate of Memory, Functional and Global Cognitive Decline in the Decade Prior to Death. J Alzheimers Dis 2021;80:683-93. [PMID: 33579840 DOI: 10.3233/JAD-201166] [Reference Citation Analysis]
26 Ciciliati AMM, Adriazola IO, Souza Farias-Itao D, Pasqualucci CA, Leite REP, Nitrini R, Grinberg LT, Jacob-Filho W, Suemoto CK. Severe Dementia Predicts Weight Loss by the Time of Death. Front Neurol 2021;12:610302. [PMID: 34054683 DOI: 10.3389/fneur.2021.610302] [Reference Citation Analysis]
27 Falgàs N, Walsh CM, Neylan TC, Grinberg LT. Deepen into sleep and wake patterns across Alzheimer's disease phenotypes. Alzheimers Dement 2021;17:1403-6. [PMID: 33710762 DOI: 10.1002/alz.12304] [Reference Citation Analysis]
28 Betts MJ, Kirilina E, Otaduy MCG, Ivanov D, Acosta-Cabronero J, Callaghan MF, Lambert C, Cardenas-Blanco A, Pine K, Passamonti L, Loane C, Keuken MC, Trujillo P, Lüsebrink F, Mattern H, Liu KY, Priovoulos N, Fliessbach K, Dahl MJ, Maaß A, Madelung CF, Meder D, Ehrenberg AJ, Speck O, Weiskopf N, Dolan R, Inglis B, Tosun D, Morawski M, Zucca FA, Siebner HR, Mather M, Uludag K, Heinsen H, Poser BA, Howard R, Zecca L, Rowe JB, Grinberg LT, Jacobs HIL, Düzel E, Hämmerer D. Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. Brain 2019;142:2558-71. [PMID: 31327002 DOI: 10.1093/brain/awz193] [Cited by in Crossref: 78] [Cited by in F6Publishing: 72] [Article Influence: 39.0] [Reference Citation Analysis]
29 Sexton CE, Sykara K, Karageorgiou E, Zitser J, Rosa T, Yaffe K, Leng Y. Connections Between Insomnia and Cognitive Aging. Neurosci Bull 2020;36:77-84. [PMID: 31222500 DOI: 10.1007/s12264-019-00401-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
30 Ehrenberg AJ, Khatun A, Coomans E, Betts MJ, Capraro F, Thijssen EH, Senkevich K, Bharucha T, Jafarpour M, Young PNE, Jagust W, Carter SF, Lashley T, Grinberg LT, Pereira JB, Mattsson-Carlgren N, Ashton NJ, Hanrieder J, Zetterberg H, Schöll M, Paterson RW. Relevance of biomarkers across different neurodegenerative diseases. Alzheimers Res Ther 2020;12:56. [PMID: 32404143 DOI: 10.1186/s13195-020-00601-w] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
31 Fertan E, Brown RE. Age-Related Deficits in Working Memory in 5xFAD Mice in the Hebb-Williams Maze. Behavioural Brain Research 2022. [DOI: 10.1016/j.bbr.2022.113806] [Reference Citation Analysis]
32 Kawakatsu S, Kobayashi R, Hayashi H, Morioka D, Utsunomiya A, Kabasawa T, Ohe R, Otani K. Clinicopathological heterogeneity of Alzheimer's disease with pure Alzheimer's disease pathology: Cases associated with dementia with Lewy bodies, very early-onset dementia, and primary progressive aphasia. Neuropathology 2021;41:427-49. [PMID: 34816507 DOI: 10.1111/neup.12765] [Reference Citation Analysis]
33 Scarpa JR, Jiang P, Gao VD, Vitaterna MH, Turek FW, Kasarskis A. NREM delta power and AD-relevant tauopathy are associated with shared cortical gene networks. Sci Rep 2021;11:7797. [PMID: 33833255 DOI: 10.1038/s41598-021-86255-6] [Reference Citation Analysis]
34 Clement A, Wiborg O, Asuni AA. Steps Towards Developing Effective Treatments for Neuropsychiatric Disturbances in Alzheimer's Disease: Insights From Preclinical Models, Clinical Data, and Future Directions. Front Aging Neurosci 2020;12:56. [PMID: 32210790 DOI: 10.3389/fnagi.2020.00056] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
35 Criado-Marrero M, Gebru NT, Blazier DM, Gould LA, Baker JD, Beaulieu-Abdelahad D, Blair LJ. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice. Acta Neuropathol Commun 2021;9:65. [PMID: 33832539 DOI: 10.1186/s40478-021-01159-w] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
36 Jacobs HIL, Riphagen JM, Ramakers IHGB, Verhey FRJ. Alzheimer's disease pathology: pathways between central norepinephrine activity, memory, and neuropsychiatric symptoms. Mol Psychiatry 2021;26:897-906. [PMID: 31138892 DOI: 10.1038/s41380-019-0437-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
37 Liu KY, Costello H, Reeves S, Howard R; Alzheimer’s Disease Neuroimaging Initiative. The Relationship Between Anxiety and Incident Agitation in Alzheimer's Disease. J Alzheimers Dis 2020;78:1119-27. [PMID: 33104025 DOI: 10.3233/JAD-200516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
38 Uiterwijk D, Stargatt R, Humphrey S, Crowe SF. The Relationship Between Cognitive Functioning and Symptoms of Depression, Anxiety, and Post-Traumatic Stress Disorder in Adults with a Traumatic Brain Injury: a Meta-Analysis. Neuropsychol Rev 2021. [PMID: 34694543 DOI: 10.1007/s11065-021-09524-1] [Reference Citation Analysis]
39 Tortajada-Soler M, Sánchez-Valdeón L, Blanco-Nistal M, Benítez-Andrades JA, Liébana-Presa C, Bayón-Darkistade E. Prevalence of Comorbidities in Individuals Diagnosed and Undiagnosed with Alzheimer's Disease in León, Spain and a Proposal for Contingency Procedures to Follow in the Case of Emergencies Involving People with Alzheimer's Disease. Int J Environ Res Public Health 2020;17:E3398. [PMID: 32414124 DOI: 10.3390/ijerph17103398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Pearce D, Gould RL, Roughley M, Reynolds G, Ward EV, Bhome R, Reeves S. Paranoid and misidentification subtypes of psychosis in dementia. Neurosci Biobehav Rev 2022;134:104529. [PMID: 35032536 DOI: 10.1016/j.neubiorev.2022.104529] [Reference Citation Analysis]
41 Naasan G, Shdo SM, Rodriguez EM, Spina S, Grinberg L, Lopez L, Karydas A, Seeley WW, Miller BL, Rankin KP. Psychosis in neurodegenerative disease: differential patterns of hallucination and delusion symptoms. Brain 2021;144:999-1012. [PMID: 33501939 DOI: 10.1093/brain/awaa413] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
42 Anor CJ, Dadar M, Collins DL, Tartaglia MC. The Longitudinal Assessment of Neuropsychiatric Symptoms in Mild Cognitive Impairment and Alzheimer's Disease and Their Association With White Matter Hyperintensities in the National Alzheimer's Coordinating Center's Uniform Data Set. Biol Psychiatry Cogn Neurosci Neuroimaging 2021;6:70-8. [PMID: 32389747 DOI: 10.1016/j.bpsc.2020.03.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
43 Falgàs N, Allen IE, Spina S, Grant H, Piña Escudero SD, Merrilees J, Gearhart R, Rosen HJ, Kramer JH, Seeley WW, Neylan TC, Miller BL, Rabinovici GD, Grinberg LT, Walsh CM. The severity of neuropsychiatric symptoms is higher in early-onset than late-onset Alzheimer's disease. Eur J Neurol 2021. [PMID: 34862834 DOI: 10.1111/ene.15203] [Reference Citation Analysis]
44 Oh J, Eser RA, Ehrenberg AJ, Morales D, Petersen C, Kudlacek J, Dunlop SR, Theofilas P, Resende EDPF, Cosme C, Alho EJL, Spina S, Walsh CM, Miller BL, Seeley WW, Bittencourt JC, Neylan TC, Heinsen H, Grinberg LT. Profound degeneration of wake-promoting neurons in Alzheimer's disease. Alzheimers Dement 2019;15:1253-63. [PMID: 31416793 DOI: 10.1016/j.jalz.2019.06.3916] [Cited by in Crossref: 35] [Cited by in F6Publishing: 28] [Article Influence: 11.7] [Reference Citation Analysis]
45 Misquitta K, Dadar M, Louis Collins D, Tartaglia MC; Alzheimer's Disease Neuroimaging Initiative. White matter hyperintensities and neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease. Neuroimage Clin 2020;28:102367. [PMID: 32798911 DOI: 10.1016/j.nicl.2020.102367] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]